These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 831465)
1. Field trial of live attenuated influenza A/B ("Alice"/R-75) vaccine. Rytel MW; Jackson LJ; Niebojewski RA; Haagensen JL; Rosenkranz MA Am J Epidemiol; 1977 Jan; 105(1):49-55. PubMed ID: 831465 [TBL] [Abstract][Full Text] [Related]
2. Use of an inhibitor-resistant live attenuated influenza vaccine in normal and asthmatic adults. Warshauer DM; Minor TE; Inhorn SL; Reed CE; Dick EC Dev Biol Stand; 1976; 33():184-90. PubMed ID: 782967 [TBL] [Abstract][Full Text] [Related]
3. A clinical trial with Alice/R-75 strain, live attenuated serum inhibitor-resistant intranasal bivalent influenza A/B vaccine. Spencer MJ; Cherry JD; Powell KR; Sumaya CV Med Microbiol Immunol; 1979 Mar; 167(1):1-9. PubMed ID: 375050 [TBL] [Abstract][Full Text] [Related]
4. New live attenuated influenza A/England/42/72 (H3N2) vaccine (Alice): reactogenicity,, immunogenicity, and protection efficacy. Rytel MW; Jackson LJ; Ferstenfeld JE; Rosenkranz MA J Infect Dis; 1975 Dec; 132(6):652-9. PubMed ID: 1202110 [TBL] [Abstract][Full Text] [Related]
5. Clinical and serologic effects of Alice strain live attenuated influenza A (H3N2) virus vaccine in an adult population. Miller LW; Togo Y; Hornick RB Med Microbiol Immunol; 1975 Dec; 162(1):15-21. PubMed ID: 1214706 [TBL] [Abstract][Full Text] [Related]
6. Attenuated influenza A vaccine (Alice) in an adult population: vaccine-related illness, serum and nasal antibody production, and intrafamily transmission. Minor TE; Dick EC; Dick CR; Inhorn SL J Clin Microbiol; 1975 Nov; 2(5):403-9. PubMed ID: 1104655 [TBL] [Abstract][Full Text] [Related]
8. A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection. Goodeve A; Potter CW; Clark A; Jennings R; Schild GC; Yetts R J Hyg (Lond); 1983 Feb; 90(1):107-15. PubMed ID: 6822725 [TBL] [Abstract][Full Text] [Related]
9. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949 [TBL] [Abstract][Full Text] [Related]
10. Clinical trials with Alice strain, live, attenuated, serum inhibitor-resistant intranasal influenza A vaccine. Spencer MJ; Cherry JD; Powell KR; Sumaya CV; Garakian AJ J Infect Dis; 1975 Oct; 132(4):415-20. PubMed ID: 1102614 [TBL] [Abstract][Full Text] [Related]
11. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. Belshe RB; Mendelman PM; Treanor J; King J; Gruber WC; Piedra P; Bernstein DI; Hayden FG; Kotloff K; Zangwill K; Iacuzio D; Wolff M N Engl J Med; 1998 May; 338(20):1405-12. PubMed ID: 9580647 [TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of "Alice" influenza virus vaccine in normal healthy adults. Zaky DA; Douglas RG; Betts RF; Roth FK; Rinehart CJ; Hogan PW J Infect Dis; 1976 Jun; 133(6):669-75. PubMed ID: 946973 [TBL] [Abstract][Full Text] [Related]
13. An attenuated influenza virus vaccine: protection against homologous and heterologous strains of virus. Khakoo R; Ganguly R; Waldman R Dev Biol Stand; 1977 Jun 1-3; 39():141-8. PubMed ID: 342305 [TBL] [Abstract][Full Text] [Related]
14. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age. Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737 [TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers. Heldens J; Hulskotte E; Voeten T; Breedveld B; Verweij P; van Duijnhoven W; Rudenko L; van Damme P; van den Bosch H Vaccine; 2014 Sep; 32(39):5118-24. PubMed ID: 24858566 [TBL] [Abstract][Full Text] [Related]
16. WRL 105 strain live attenuated influenza vaccine; comparison of one and two dose schedules. Evans AE; Letley E; Ferris RD; Freestone DS J Hyg (Lond); 1976 Dec; 77(3):327-32. PubMed ID: 1069813 [TBL] [Abstract][Full Text] [Related]
17. Live attenuated influenza virus vaccines in patients with chronic broncho-pulmonary diseases. Clinical and immunological evaluation. Prevost JM; Vereerstraeten-Schmerber J; Lamy F; De Koster JP Scand J Respir Dis; 1975 May; 56(1):58-69. PubMed ID: 1096297 [TBL] [Abstract][Full Text] [Related]
18. Reactogenicity and immunogenicity of whole and ether-Tween-split influenza A virus vaccines in volunteers. Jennings R; Clark A; Oxford JS; Hockley DJ; Potter CW J Infect Dis; 1978 Nov; 138(5):577-86. PubMed ID: 712115 [TBL] [Abstract][Full Text] [Related]
19. Small-scale trial of live-attenuated influenza vaccine (A/Hong Kong/68). West R; Stewart JA; White FM; McDonald JC; Boudreault A; Pavilanis V Can J Microbiol; 1977 Mar; 23(3):253-7. PubMed ID: 322827 [TBL] [Abstract][Full Text] [Related]
20. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. Ohmit SE; Petrie JG; Cross RT; Johnson E; Monto AS J Infect Dis; 2011 Dec; 204(12):1879-85. PubMed ID: 21998477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]